TSTL Share Price Performance
UK£3.65
-1.02 (-21.93%)
18.1% undervalued intrinsic discount
UK£4.46
Fair Value
Price UK£3.65
AnalystConsensusTarget UK£4.46
Fair ValueUK£4.46
Share PriceUK£3.65
18.1% undervalued intrinsic discount
TSTL Community Narratives
AN
Fair Value UK£4.46 18.1% undervalued intrinsic discount
US Expansion And Direct Sales Will Open New Opportunities
0users have liked this narrative
0users have commented on this narrative
9users have followed this narrative
TSTL Community Fair Values
- UK£4.46FV18.1% undervalued intrinsic discount11.31%Revenue growth p.a.0users have liked this narrative0users have commented on this narrative9users have followed this narrative11 days ago author updated this narrative
Recent TSTL News & Updates
No updates
Tristel plc Key Details
Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 0.13
- Gross Margin
- 81.42%
- Net Profit Margin
- 14.09%
- Debt/Equity Ratio
- 0%
Tristel plc Competitors
About TSTL
- Founded
- 1993
- Employees
- 233
- CEO
- WebsiteView website
Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. The company operates through three segments, Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers device decontamination products, including wipes system, ULT, OPH, Stella system, fuse for Stella, rinse assure, clean, EVE, medistel, EVA system, daisygrip, fuse for surfaces, dosing system, airstel, enzystel, DOK, pre-clean wipes, rinse wipes, sporicidal wipes, clean for Stella, protect, and wipes; surface disinfection products, such as FUSE, JET, JET LUX, JET PRO, TANK 10 CLO2, TANK 5 CLO2, and TILT 5 CLO2; as well as operates 3T, a cloud-based platform alternative to paper-based traceability systems. The company provides its medical disinfection products, including airway management, cardiology, ear, nose and throat, endoscopy, gastrointestinal physiology, laboratory, ophthalmology, phlebotomy, reproductive health/IVF, surface, ultrasound, urology, women's health, and other products under the Tristel brand. Tristel plc was founded in 1993 and is headquartered in Snailwell, the United Kingdom.
U.K. Market Performance
- 7 Days: -2.5%
- 3 Months: 17.0%
- 1 Year: 12.4%
- Year to Date: 12.2%
Over the last 7 days, the market has dropped 2.5%, driven by a pullback of 2.3% in the Financials sector. In the last year, the market is actually up 12%. Looking forward, earnings are forecast to grow by 13% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading